|
Showing the most relevant articles for your search:AMEX:ANX | Date | Time | Source | Headline | Symbol | Company | | 04/25/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/23/2007 | 7:00AM | PR Newswire (US) | ADVENTRX ANX-201 Abstract Accepted for Presentation at International AIDS Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/18/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Announces Positive Data From Multidrug Therapy With CoFactor | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/11/2007 | 7:00AM | PR Newswire (US) | ADVENTRX to Present at 7th Annual Fortis Biotech Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/05/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Grants Manufacturing Contract for ANX-514 (Docetaxel Emulsion) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/05/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Grants Manufacturing Contract for ANX-514 (Docetaxel Emulsion) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/02/2007 | 7:00AM | PR Newswire (US) | ADVENTRX to Present at CIBC Annual Biotechnology and Specialty Pharmaceuticals Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/29/2007 | 7:00AM | PR Newswire (US) | ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual Meeting | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/26/2007 | 7:00AM | PR Newswire (US) | ADVENTRX and TRx Pharma Announce Zanaflu(R) Registered as the Brand Name for ANX-211 (Chitosan Gel) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/20/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Awards Manufacturing Contract for ANX-201 (Thiovir(TM)) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/15/2007 | 5:00PM | PR Newswire (US) | ADVENTRX Pharmaceuticals, Inc. Announces Fourth Quarter and Year 2006 Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/13/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Appoints Vice President of Regulatory Affairs | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/07/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Report Fourth Quarter and Full Year 2006 Financial Results on March 15, 2007 | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/06/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Announces M. Ross Johnson to Retire as Board Chairman | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/28/2007 | 5:00AM | PR Newswire (US) | ADVENTRX to Present at BIO-Europe Spring Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/12/2007 | 6:30AM | PR Newswire (US) | ADVENTRX to Present Thiovir Preclinical Data at the 20th International Conference on Antiviral Research | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/05/2007 | 12:17PM | PR Newswire (US) | ADVENTRX to Present at BIO CEO Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/22/2007 | 9:00AM | PR Newswire (US) | American Stock Exchange to Host First Annual Healthcare Conference in Boston on February 8, 2007 | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/22/2007 | 6:00AM | PR Newswire (US) | ADVENTRX to Present at the American Stock Exchange First Annual Healthcare Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/27/2006 | 6:00AM | PR Newswire (US) | ADVENTRX Initiates CoFactor Phase II Clinical Trial in Refractory Breast Cancer | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/26/2006 | 6:00AM | PR Newswire (US) | ADVENTRX Cleared to Initiate Vinorelbine Emulsion Bioequivalence Study | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/20/2006 | 6:00AM | PR Newswire (US) | ADVENTRX Announces Appointment of Veteran Finance and Biotech Industry Executive Gregory P. Hanson as Chief Financial Officer | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/07/2006 | 6:18AM | PR Newswire (US) | ADVENTRX to Participate at the RBC Capital Markets Healthcare Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/14/2006 | 6:00AM | PR Newswire (US) | ADVENTRX to Present at BIOCOM San Diego Investor Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/10/2006 | 6:00AM | PR Newswire (US) | ADVENTRX Completes $40 Million Sale of Common Stock | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/09/2006 | 5:00PM | PR Newswire (US) | ADVENTRX Announces 2006 Third Quarter Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/03/2006 | 6:00AM | PR Newswire (US) | ADVENTRX Announces $40 Million Common Stock Offering | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/31/2006 | 9:00AM | PR Newswire (US) | ADVENTRX to Present at November Investor and Partnering Conferences | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/26/2006 | 2:43PM | PR Newswire (US) | ADVENTRX Announces Board Change | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/23/2006 | 4:15AM | PR Newswire (US) | ADVENTRX Licenses Proprietary Antiviral Product to Theragenex | AMEX:ANX | Mast Therapeutics, Inc. |
|
Showing the most relevant articles for your search:AMEX:ANX |
|